期刊文献+

^(18)F-FDG hPET/CT显像在腹部消化系肿瘤的应用 被引量:2

Evaluation of abdominal digestive tumors with ^(18)F-FDG coincidence imaging
暂未订购
导出
摘要 目的 评价1 8F 脱氧葡萄糖 (FDG)符合线路显像结合图像融合 (hPET CT)探测可疑腹部消化系恶性肿瘤或肿瘤复发的临床价值。方法 对 5 1例临床怀疑为腹部消化系恶性肿瘤或肿瘤复发患者行1 8F FDG符合线路显像 ,经迭代法处理和重建 ,获得经检查衰减校正后的断层图像和融合图像 ,以目测双盲阅片进行诊断分析 ,并与手术病理检查或CT和 (或 )MRI、临床随访作出的最后诊断结果进行对比。结果 1 8F FDG符合线路显像对腹部消化系肿瘤诊断的灵敏度、特异性和准确性分别为 94 1% ,76 5 %和 88 2 % ;对结直肠癌复发的诊断灵敏度为 94 1% ,特异性为 83 3% ,准确性为91 3%。结论 1 8F FDG符合线路显像对腹部消化系恶性肿瘤或肿瘤复发的诊断具有较高的灵敏度和准确性。 Objective To evaluate the clinical usefulness of 18F-fluorodeoxyglucose (FDG) coincidence imaging in detecting suspected abdominal digestive tumors or recurrent cancer. Methods 51 patients with suspected abdominal digestive malignant tumors or recurrent cancer underwent 18F-FDG coincidence imaging using GE HAWKEYE coincidence SPECT at 40~60 min after the intravenous injection of 259~298 MBq 18F-FDG. The acquired data were reconstructed using iterative algorithm, attenuation-corrected using X ray and fused using CT. The images were interpretated visually by nuclear physician with double blindness. The results were also compared and assessed with the clinical diagnosis, histological examination CT and MRI findings. Results In all patients with suspected abdominal digestive malignant tumors, the sensitivity, specificity and accuracy of 18F-FDG coincidence imaging was 94.1%, 76.5% and 88.2% respectively. And in the patients with colorectal recurrent cancer, the sensitivity, specificity and accuracy were 94.1%, 83.3% and 91.3% respectively. Conclusion 18F-FDG coincidence imaging had highly sensitivity and accuracy in diagnosis of abdominal digestive malignant tumor or recurrent cancer.
出处 《中华核医学杂志》 CAS CSCD 北大核心 2003年第4期206-207,共2页 Chinese Journal of Nuclear Medicine
关键词 腹部消化系肿瘤 ^18F—FDGhPET CT 诊断 放射性核素显像 Digestive system neoplasms Neoplasm recurrence, local Tomography, emission-computed, single-photon Deoxyglucose
  • 相关文献

参考文献4

  • 1金少津,Scott,AM.^(18)F-FDG PET肿瘤学应用进展[J].国外医学(放射医学核医学分册),1999,23(1):1-4. 被引量:5
  • 2Kunishima S, Taniguchi H, Yamaguchi A, et al. Evaluation of abdominal tumors with ^18F-fluorodeoxyglucose positron emission tomography. Clin Positron Imaging, 2000, 3: 91-96.
  • 3Valk PE, Abella-Columa E, Hasceman MK, et al. Whole-body PET imaging with ^18F-fluorodeoxyglucose in management of recurrent colorectal cancer. Arch Surg, 1999, 134: 503-511.
  • 4Okazumi S, Isono K, Enomoto K, et al. Evaluation of liver tumors using ^18F-fluorodeoxyglucose PET. J Nucl Med, 1992, 33: 333-339.

共引文献4

同被引文献12

  • 1Flamen P, Lerut A, Van Cutsem E, et al. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol, 2000,18 : 3202-3210.
  • 2Paul AK, Tatsumi M, Higuchi I, et al. Gamma camera coincidence imaging with ^18 F-fluorodeoxyglucose in the pretreatment evaluation of patients with oesophageal cancer. Nucl Meal Commun, 2003, 24: 963 -970.
  • 3Yoon YC, Lee KS, Shim YM, et al. Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection prospective study. Radiology, 2003, 227 : 764-770.
  • 4Law SY, Fok M, Wong J. Pattern of recurrence after oesophageal resection for cancer: clinical implications. Br J Surg, 1996, 83: 107- 111.
  • 5Kato H, Miyazaki T, Nakajima M, et al. Value of positron emission tomography in the diagnosis of recurrent oesophageal carcinoma. Br J Surg, 2004, 91: 1004-1009.
  • 6Flamen P, Lerut A, Van Cutsem E, et al. The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer. J Thorac Cardiovasc Surg, 2000, 120: 1085-1092.
  • 7Vesseile HJ, Miraldi FD. FDG PET of the retroperitoneum: normal anatomy, variants, pathologic conditions, and strategies to avoid diagnostic pitfalls. Radiographics, 1998, 18 : 805-823.
  • 8Skehan SJ, Brown AL, Thomopson M, et al. Imaging features of primary and recurrent esophageal cancer at FDG PET. Radiographics, 2000, 20: 713-723.
  • 9Basu S. 18 F -- FDG PET/CT as a sensitive and early treatment monito- ring tool: will this become the major thrust for its clinical application in infectious and inflammatory disorders[ J] ? J Nucl Med, 2012,53 ( 1 ) : 165 - 166.
  • 10Whitson BA, Groth SS, Maddaus MA, et al. Recommendations for opti- mal use of imaging studies to clinically stage mediastinal lymph nodes in non - small - cell lung cancer patients [ J ]. Lung Cancer, 2008,61 (2) :177 - 185.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部